Eupraxia Pharmaceuticals has disclosed additional positive data from its Phase Ib/IIa RESOLVE clinical trial of EP-104GI in treating eosinophilic esophagitis (EoE). The multicentre, open-label, ...

A reduction in SDI is a positive outcome for the RESOLVE trial. 2. In the Eosinophilic Esophagitis Histology Scoring System, or EoEHSS, grade indicates the severity of each of the eight ...

A condition known as eosinophilic esophagitis, or EoE, affects one in 1,500 kids. They actually have an allergic reaction ...

In these phase 3A, randomized, placebo-controlled replicate trials, we evaluated the efficacy and safety of depemokimab in patients with severe asthma and an eosinophilic ... (P.E.P.), and GSK ...

Confirming the results of Study A, this second pivotal trial in biologic-naïve patients met primary and key secondary endpoints, showing ...

AstraZeneca’s FASENRA ® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). 1 EGPA is a rare, immune-mediated ...

We’ve all seen them and some of us have one at home: picky eaters. A toddler that just won’t eat, no matter what you put on their plate. Well, it may be just a phase, or it may be something more ...

There is moderate to abundant eosinophilic cytoplasm (×20 ... Neuroendocrine markers (d) synaptophysin and (e) chromogranin are positive in tumor cells (×20), and (f) proliferation labeling index with ...

Degenerated urothelial cells present with shrunken (condensed), dark nuclei with mildly irregular nuclear borders, granular cytoplasm, and eosinophilic and/or cyanophilic intracytoplasmic inclusions ...

Study reviews transplant-acquired food allergies, focusing on pediatric patients, particularly liver transplant recipients.

The partnership will see the application of AI-enabled screening to address bioavailability issues with Equillium’s ...